← FDA Drug Approvals (Drugs@FDA)
RISPERIDONE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: JUBILANT GENERICS · Approved 2011-11-04
Drug application
- FDA Application #
ANDA090839- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- RISPERIDONE
- Generic name
- RISPERIDONE
- Active ingredients
- RISPERIDONE
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- JUBILANT GENERICS
- Manufacturer
- Jubilant Cadista Pharmacuticals Inc.
- First approval
- 2011-11-04
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown